Enhanced optineurin E50K–TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Glaucoma is the leading cause for blindness affecting 60 million people worldwide. The optineurin (OPTN) E50K mutation was first identified in familial primary open-angle glaucoma (POAG), the onset of which is not associated with intraocular pressure (IOP) elevation, and is classified as normal-tension glaucoma (NTG). Optineurin (OPTN) is a multifunctional protein and its mutations are associated with neurodegenerative diseases such as POAG and amyotrophic lateral sclerosis (ALS). We have previously described an E50K mutation-carrying transgenic (E50K-tg) mouse that exhibited glaucomatous phenotypes of decreased retinal ganglion cells (RGCs) and surrounding cell death at normal IOP. Further phenotypic analysis of these mice revealed persistent reactive gliosis and E50K mutant protein deposits in the outer plexiform layer (OPL). Over-expression of E50K in HEK293 cells indicated accumulation of insoluble OPTN in the endoplasmic reticulum (ER). This phenomenon was consistent with the results seen in neurons derived from induced pluripotent stem cells (iPSCs) from E50K mutation-carrying NTG patients. The E50K mutant strongly interacted with TANK-binding kinase 1 (TBK1), which prohibited the proper oligomerization and solubility of OPTN, both of which are important for OPTN intracellular transition. Treatment with a TBK1 inhibitor, BX795, abrogated the aberrant insolubility of the E50K mutant. Here, we delineated the intracellular dynamics of the endogenous E50K mutant protein for the first time and demonstrated how this mutation causes OPTN insolubility, in association with TBK1, to evoke POAG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“When harboring genetic mutations associated with disease states, the derivation of these cells from patient-specific sources allows for the ability to study mechanisms underlying diseases, such as glaucoma (Inagaki et al., 2018, Minegishi et al., 2013, Ohlemacher et al., 2016, Teotia et al., 2017b).”
From Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids (2020) · cites this paper as Minegishi et al., 2013
In the citing paper
“Transgenic mice overexpressing the OPTNE50K mutation, which instigates the formation of insoluble OPTN aggregates and results in autophagy blockade, display RGC loss and reduced retinal thickness (Chi et al, 2010; Minegishi et al, 2013).”
From Autophagy in major human diseases (2021) · cites this paper as Minegishi et al, 2013
In the citing paper
“suggesting that a loss of OPTN function or a gain of toxic function likely contributes to disease pathogenesis [82, 83].”
In the citing paper
“Enhanced OPTN binding to TBK1 and increased production of insoluble OPTN has been previously observed in E50K mutant cells”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
pEF-BOS, a powerful mammalian expression vector
Mizushima, S., & Nagata, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5322 · Cited by 1,605
STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway
Tanaka, Y., & Chen, Z. J. (2012) · Science Signaling · doi:10.1126/scisignal.2002521 · Cited by 1,317
Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth
Wild, P., Farhan, H., McEwan, D. G., Wagner, S., Rogov, V. V., Brady, N. R., Richter, B., Korac, J., Waidmann, O., Choudhary, C., et al. (2011) · Science · doi:10.1126/science.1205405 · Cited by 1,298
Mutations of optineurin in amyotrophic lateral sclerosis
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265
Quigley, H. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61423-7 · Cited by 1,121
Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin
Rezaie, T., Child, A., Hitchings, R., Brice, G., Miller, L., Coca-Prados, M., Héon, E., Krupin, T., Ritch, R., Kreutzer, D., et al. (2002) · Science · doi:10.1126/science.1066901 · Cited by 1,105
The prevalence of primary open-angle glaucoma in Japanese
Iwase, A., Suzuki, Y., Araie, M., Yamamoto, T., Abe, H., Shirato, S., Kuwayama, Y., Mishima, H. K., Shimizu, H., Tomita, G., et al. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.03.029 · Cited by 872
Self-citationAtg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response
Saitoh, T., Fujita, N., Hayashi, T., Takahara, K., Satoh, T., Lee, H., Matsunaga, K., Kageyama, S., Omori, H., Noda, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911267106 · Cited by 854
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
Self-citationTsuji, O., Miura, K., Okada, Y., Fujiyoshi, K., Mukaino, M., Nagoshi, N., Kitamura, K., Kumagai, G., Nishino, M., Tomisato, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910106107 · Cited by 518
Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis
Sahlender, D. A., Roberts, R. C., Arden, S. D., Spudich, G., Taylor, M. J., Luzio, J. P., Kendrick-Jones, J., & Buss, F. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501162 · Cited by 426
Risk Factors for Open-Angle Glaucoma in a Japanese PopulationThe Tajimi Study
SUZUKI, Y., IWASE, A., ARAIE, M., YAMAMOTO, T., ABE, H., SHIRATO, S., KUWAYAMA, Y., MISHIMA, H., SHIMIZU, H., & TOMITA, G. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.03.059 · Cited by 398
Self-citationClark, K., Plater, L., Peggie, M., & Cohen, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000414 · Cited by 385
Imaizumi, Y., Okada, Y., Akamatsu, W., Koike, M., Kuzumaki, N., Hayakawa, H., Nihira, T., Kobayashi, T., Ohyama, M., Sato, S., et al. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-35 · Cited by 380
Copy number variations on chromosome 12q14 in patients with normal tension glaucoma
Fingert, J. H., Robin, A. L., Stone, J. L., Roos, B. R., Davis, L. K., Scheetz, T. E., Bennett, S. R., Wassink, T. H., Kwon, Y. H., Alward, W. L. M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr123 · Cited by 222
Tucker, B. A., Scheetz, T. E., Mullins, R. F., DeLuca, A. P., Hoffmann, J. M., Johnston, R. M., Jacobson, S. G., Sheffield, V. C., & Stone, E. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108918108 · Cited by 207
Nukina, N., Kosik, K. S., & Selkoe, D. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3415 · Cited by 198
Morton, S., Hesson, L., Peggie, M., & Cohen, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.047 · Cited by 181
Hoffner, G., Kahlem, P., & Djian, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.941 · Cited by 180
Gleason, C. E., Ordureau, A., Gourlay, R., Arthur, J. S. C., & Cohen, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267567 · Cited by 173
Chi, Z.-L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., Tomarev, S., Kawase, K., Yamamoto, T., Noda, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq146 · Cited by 151
Self-citationShaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
Clinical Features and Course of Patients with Glaucoma with the E50K Mutation in the Optineurin Gene
Aung, T., Rezaie, T., Okada, K., Viswanathan, A. C., Child, A. H., Brice, G., Bhattacharya, S. S., Lehmann, O. J., Sarfarazi, M., & Hitchings, R. A. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1133 · Cited by 125
Mechanisms of polarized membrane trafficking in neurons — focusing in on endosomes
Lasiecka, Z. M., & Winckler, B. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.06.013 · Cited by 124
Cellular and Molecular Biology of Optineurin
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00005-7 · Cited by 122
Chalasani, M. L., Radha, V., Gupta, V., Agarwal, N., Balasubramanian, D., & Swarup, G. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0834 · Cited by 118
Nagabhushana, A., Chalasani, M. L., Jain, N., Radha, V., Rangaraj, N., Balasubramanian, D., & Swarup, G. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-4 · Cited by 110
Giani, A., Thanos, A., Roh, M. I., Connolly, E., Trichonas, G., Kim, I., Gragoudas, E., Vavvas, D., & Miller, J. W. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6266 · Cited by 97
Hauser, M. A., Sena, D. F., Flor, J., Walter, J., Auguste, J., LaRocque-Abramson, K., Graham, F., DelBono, E., Haines, J. L., Pericak-Vance, M. A., et al. (2006) · Journal of Glaucoma · doi:10.1097/01.ijg.0000212255.17950.42 · Cited by 94
Bond, L. M., Peden, A. A., Kendrick-Jones, J., Sellers, J. R., & Buss, F. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0553 · Cited by 92
Processing of Optineurin in Neuronal Cells
Shen, X., Ying, H., Qiu, Y., Park, J.-S., Shyam, R., Chi, Z.-L., Iwata, T., & Yue, B. Y. J. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175810 · Cited by 88
Self-citationStudies of Optineurin, a Glaucoma Gene
Park, B.-C., Shen, X., Samaraweera, M., & Yue, B. Y. J. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060400 · Cited by 86
Inhibition of Reactive Gliosis Attenuates Excitotoxicity-Mediated Death of Retinal Ganglion Cells
Ganesh, B. S., & Chintala, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018305 · Cited by 82
Optineurin in primary open angle glaucoma
Sarfarazi, M., & Rezaie, T. (2003) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(03)00061-0 · Cited by 78
関, 倫. (2011) · Medical Entomology and Zoology · Cited by 75
Confirmation of TBK1 duplication in normal tension glaucoma
Kawase, K., Allingham, R. R., Meguro, A., Mizuki, N., Roos, B., Solivan-Timpe, F. M., Robin, A. L., Ritch, R., & Fingert, J. H. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2011.12.021 · Cited by 74
Self-citationKryndushkin, D. S., Ihrke, G., Piermartiri, T., & Shewmaker, F. P. (2012) · Molecular Microbiology · doi:10.1111/mmi.12075 · Cited by 69
Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation
Ito, H., Nakamura, M., Komure, O., Ayaki, T., Wate, R., Maruyama, H., Nakamura, Y., Fujita, K., Kaneko, S., Okamoto, Y., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0842-y · Cited by 68
Wurm, A., Iandiev, I., Uhlmann, S., Wiedemann, P., Reichenbach, A., Bringmann, A., & Pannicke, T. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6901 · Cited by 49
Farhan, H., Freissmuth, M., & Sitte, H. H. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-29784-7_12 · Cited by 47
Sippl, C., Bosserhoff, A., Fischer, D., & Tamm, E. R. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.08.011 · Cited by 47
Retinal blood vessels are damaged in a rat model of NMDA-induced retinal degeneration
Ueda, K., Nakahara, T., Hoshino, M., Mori, A., Sakamoto, K., & Ishii, K. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.061 · Cited by 41
Meng, Q., Lv, J., Ge, H., Zhang, L., Xue, F., Zhu, Y., & Liu, P. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-1397-7 · Cited by 25
TBK1and Flanking Genes in Human Retina
Fingert, J. H., Darbro, B. W., Qian, Q., Rheeden, R. V. V., Miller, K., Riker, M. J., Solivan-Timpe, F., Roos, B. R., Robin, A. L., & Mullins, R. F. (2013) · Ophthalmic Genetics · doi:10.3109/13816810.2013.768674 · Cited by 18
Seo, S., Solivan-Timpe, F., Roos, B. R., Robin, A. L., Stone, E. M., Kwon, Y. H., Alward, W. L. M., & Fingert, J. H. (2013) · Current Eye Research · doi:10.3109/02713683.2012.754047 · Cited by 11
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Endoplasmic reticulum stress: molecular mechanism and therapeutic targets
Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,007
Weinreb, R. N., Leung, C. K. S., Crowston, J. G., Medeiros, F. A., Friedman, D. S., Wiggs, J. L., & Martin, K. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.67 · Cited by 632
Wiggs, J. L., & Pasquale, L. R. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx184 · Cited by 373
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370
“E50K mutation in OPTN leads to enhanced interaction of OPTN with TBK1 (Li et al., 2016; Minegishi et al., 2013), and its overexpression leads to RGC death (Chalasani et al.”
Background
Metadata
- Authors
- Minegishi, Y., Iejima, D., Kobayashi, H., Chi, Z.-L., Kawase, K., Yamamoto, T., Seki, T., Yuasa, S., Fukuda, K., & Iwata, T.
- Affiliations
- Tokyo Medical Center (JP)
- Gifu University (JP)
- Keio University (JP)
- Corresponding author
- Iwata, Takeshi
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-05-12
- Volume
- 22
- Issue
- 17
- Pages
- 3559-3567
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2138674139
- Cited by
- 138
- References
- 47
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 10 · 2016: 20 · 2015: 19 · 2014: 8 · 2013: 3
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24791885)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- optineurin, normal-tension glaucoma, TBK1, protein insolubility, protein aggregation, retinal ganglion cells, reactive gliosis, outer plexiform layer, endoplasmic reticulum, protein oligomerization, BX795, TBK1 inhibitors, iPSC-derived neurons, transgenic mouse model
- MeSH terms
- Animals, Disease Models, Animal, Endoplasmic Reticulum, Glaucoma, Open-Angle, Gliosis, Humans, Mice, Transgenic, Pyrimidines, Retina, Thiophenes, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Membrane Transport Proteins, Transcription Factor TFIIIA, Mice, Induced Pluripotent Stem Cells, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.